Literature DB >> 12675124

Characterization of muscarinic autoreceptors in the rabbit hippocampus and caudate nucleus.

C Stoll1, U Schwarzwälder, S Johann, G Lambrecht, G Hertting, T J Feuerstein, R Jackisch.   

Abstract

Oxotremorine-induced inhibition of electrically evoked release of 3H-acetylcholine from brain slices preincubated with 3H-choline was used to characterize muscarinic autoreceptors in rabbit hippocampus and caudate nucleus. From the shifts to the right of the concentration-response curves of oxotremorine in the presence of muscarinic receptor antagonists, the following pKB values [95% C.I.] were determined in the hippocampus: tripinamide: 8.7 [8.5, 8.8]; himbacine: 8.4 [8.3, 8.5]; AQ-RA 741: 8.3 [8.2, 8.5]; 4-DAMP: 8.2 [8.0, 8.3]; hexahydrosiladifenidol: 7.4 [7.2, 7.5]; AF-DX 116: 7.3 [7.1, 7.4]; pirenzepine: 6.8 [6.6, 7.0]; and PD102807: 6.3 [6.0, 6.5]. In the caudate nucleus: tripinamide: 9.1 [8.9, 9.2]; 4-DAMP: 8.3 [8.2, 8.5]; himbacine: 8.1 [8.0, 8.2]; AQ-RA 741: 8.1 [8.0, 8.3]; hexahydrosiladifenidol: 7.3 [7.2, 7.4]; AF-DX 116: 7.1 [7.0, 7.2]; pirenzepine: 6.7 [6.6, 6.8]; and PD102807: 6.5 [6.2, 6.8]. These pKB values fit best to literature values for M2 receptors, suggesting that the muscarinic autoreceptor of the rabbit hippocampus and caudate nucleus is the m2 gene product.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675124     DOI: 10.1023/a:1022836315383

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type.

Authors:  K Kitaichi; J C Day; R Quirion
Journal:  Eur J Pharmacol       Date:  1999-10-21       Impact factor: 4.432

2.  Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle.

Authors:  J Gross; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-10       Impact factor: 3.000

Review 3.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

4.  Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus.

Authors:  K Kitaichi; T Hori; L K Srivastava; R Quirion
Journal:  Brain Res Mol Brain Res       Date:  1999-04-06

5.  The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

6.  Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data.

Authors:  W Billard; H Binch; G Crosby; R D McQuade
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

7.  Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.

Authors:  M L Bolognesi; A Minarini; R Budriesi; S Cacciaguerra; A Chiarini; S Spampinato; V Tumiatti; C Melchiorre
Journal:  J Med Chem       Date:  1998-10-08       Impact factor: 7.446

8.  Pharmacological characterization of the rat hippocampal muscarinic autoreceptor.

Authors:  M McKinney; J H Miller; P J Aagaard
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

9.  Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.

Authors:  R Quirion; A Wilson; W Rowe; I Aubert; J Richard; H Doods; A Parent; N White; M J Meaney
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  1 in total

1.  Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex.

Authors:  S Gigout; S Wierschke; C Dehnicke; R A Deisz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-16       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.